Epidemiologic trends in head and neck cancer and aids in diagnosis.
Epidemiologic trends in head and neck cancer and aids in diagnosis.
复制标题
DOI:
10.1016/j.coms.2014.01.001
复制
发表时间:
2014-05
影响因子:
1.5
通讯作者:
Williams, Michelle D.
中科院分区:
文献类型:
--
作者:
Vigneswaran, Nadarajah;Williams, Michelle D.
Head and neck cancers represent the sixth most common cancer worldwide with approximately 630,000 new patients diagnosed annually resulting in more than 350,000 deaths every year 1. More than 90% of head and neck cancers are squamous cell carcinomas (HNSCC) that arise from the mucosal surfaces of the oral cavity (OSCC, ICD-10 code: C00-08), oropharynx (OPSCC, ICD-10 code: C09-10 and C12-14) and larynx (ICD-10 code C32-9). While in Northern America and Europe, HNSCC accounts for 5-10% of all new cancer cases, there is wide geographical variation in the incidence and anatomic distribution of HNSCC worldwide. This variation is predominately attributed to demographic differences in the habits of tobacco use and alcohol consumption which contributes to the development of almost 80% of all HNSCC diagnosed globally. In high-risk countries (ie India, Sri Lanka, Bangladesh and Pakistan), OSCC is the most common cancer in men and the third most common cancer in women2. Among the European countries, the highest incidence of OSCC is in France with high rates also noted in Hungary, Slovakia and Slovenia2. In the United States (US), HNSCC constitutes only the eighth most common cancer among men with approximately 53,600 patients diagnosed yearly and shows a considerably lower mortality with 11,500 patient deaths annually3. The decreasing incidence of OSCC and laryngeal SCC in the US and in other developed countries coincides with decline in the use of tobacco products 4. By contrast, there is a recent upsurge in the incidence of oropharyngeal squamous cell carcinoma (OPSCC) which is attributed to a change in the biologic driver of SCC in this region with an increasing frequency of an association with high-risk subtypes of human papilloma virus (HPV) 4, 5. HPV associated© 2014 Elsevier Inc. All rights reserved. Corresponding Author: 77054 713-486-4410 tel| 713-486-4416 fax nadarajah. vigneswaran@ uth. tmc. edu; www. db. uth. tmc. edu 713-794-1765 tel|, 713-563-1848 fax mdwillia@ mdanderson. org.
登录
查看更多内容
DOI:
10.1158/1055-9965.epi-13-0135
发表时间:
2013-04
期刊:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
影响因子:
--
作者:
Caporaso NE
通讯作者:
Caporaso NE
影响因子:
4.8
作者:
Fakhry, Carole;D'Souza, Gypsyamber
通讯作者:
D'Souza, Gypsyamber
DOI:
10.14219/jada.archive.2012.0096
发表时间:
2012-12-01
影响因子:
3.9
作者:
Epstein, Joel B.;Guneri, Pelin;Abt, Elliot
通讯作者:
Abt, Elliot
DOI:
10.1002/hed.21131
发表时间:
2009-12-01
影响因子:
2.9
作者:
Mehanna, Hisham M.;Rattay, Tim;McConkey, Christopher C.
通讯作者:
McConkey, Christopher C.
影响因子:
--
作者:
Kutler, DI;Auerbach, AD;Singh, B
通讯作者:
Singh, B